Literature DB >> 1922675

Subcellular distribution of corticotropin-releasing-factor-like immunoreactivity in rat central nervous system.

S T Cain1, M J Owens, C B Nemeroff.   

Abstract

Corticotropin-releasing-factor-like immunoreactivity (CRF-LI) was measured in a number of subcellular fractions from rat brain using a highly sensitive and specific radioimmunoassay. CRF-LI was highly enriched in the crude synaptosomal/mitochondrial fraction (P2) relative to the homogenate, P1, S1, and S2 fractions. Separation of the P2 fraction into synaptosomal, myelin, and mitochondria-enriched subfractions on a rapid one-step sucrose gradient revealed that CRF-LI was present at higher concentration in the synaptosomal fraction than in the mitochondrial and myelin fractions. The distribution of CRF-LI paralleled that of synapsin, a synaptic vesicle marker phosphoprotein, but not that of pyruvate dehydrogenase, a mitochondrial phosphoprotein. These results are consistent with a nerve terminal localization of CRF and a potential role for this peptide as a central nervous system neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922675     DOI: 10.1159/000125848

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  3 in total

1.  CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.

Authors:  Florence P Varodayan; Diego Correia; Dean Kirson; Sophia Khom; Christopher S Oleata; George Luu; Paul Schweitzer; Marisa Roberto
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

Review 2.  Synaptic physiology of central CRH system.

Authors:  Joel P Gallagher; Luis F Orozco-Cabal; Jie Liu; Patricia Shinnick-Gallagher
Journal:  Eur J Pharmacol       Date:  2008-02-01       Impact factor: 4.432

3.  Corticotropin-releasing factor facilitates epileptiform activity in the entorhinal cortex: roles of CRF2 receptors and PKA pathway.

Authors:  Lalitha Kurada; Chuanxiu Yang; Saobo Lei
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.